Fundz

Secretome Therapeutics reported raising $6.85 Million in an initial SEC Form D filing, from an offering of $10.9 Million

PRIVATEFeb 02, 2023$6.9M of $10.9M raised

Amount Raised

$6.85 Million

$6.85 Million sold, per SEC Form D (first sale Nov 23, 2022)

Round Type

Venture

BaltimoreBiotechnology

Quick answer

Secretome Therapeutics raised $6.85 Million in a funding round, dated November 23, 2022. Secretome Therapeutics is based in Baltimore, Maryland, United States.

How much did Secretome Therapeutics raise?
Secretome Therapeutics raised $6.85 Million in a funding round on November 23, 2022.
What does Secretome Therapeutics do?
Secretome Therapeutics is developing a platform of first-in-class therapeutics derived from neonatal mesenchymal stem cells (nMSC) for the treatment and prevention of underserved diseases.
Where is Secretome Therapeutics based and how big is it?
Secretome Therapeutics is based in Baltimore, Maryland, United States. Fundz records about 16 employees.
Who are the decision-makers at Secretome Therapeutics?
Fundz holds 2 contacts at Secretome Therapeutics, including the Director Translational Medicine. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Secretome Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
  • Vitro Biopharma raised $993K (Seed) on January 6, 2023.
  • Synthekine raised $100M (Series C) on January 6, 2023.
  • Amolyt Pharma raised $138M (Series C) on January 6, 2023.
  • Cambium Analytica raised $3.8M (Seed) on January 6, 2023.
  • Byonyks Medical Devices raised $1M (Seed) on January 6, 2023.

Who to call at Secretome Therapeutics, and when

A new round usually means Secretome Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Secretome Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Secretome Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Secretome Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Secretome Therapeutics

Location

323 W Camden St, Suite 600

Baltimore, Maryland, United States

About

Secretome Therapeutics is developing a platform of first-in-class therapeutics derived from neonatal mesenchymal stem cells (nMSC) for the treatment and prevention of underserved diseases. Our lead product, STM-21, is a novel secretome in development for adult and pediatric forms of heart failure, and our pipeline includes novel secretomes in development for neurodegenerative and dermatological diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Secretome Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMuthukumar P., Director Translational Medicine hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Secretome Therapeutics's next move

See what Strategic adds

Secretome Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.